MRI for Eval Tumor & Node Response & Normal Tissue Function to Concurrent Chemo & Radiation Therapy in H&N Cancer (GCC1043)
CompletedOBSERVATIONAL
Enrollment
30
Participants
Timeline
Start Date
September 30, 2011
Primary Completion Date
September 30, 2018
Study Completion Date
January 31, 2019
Conditions
Head and Neck Cancer
Trial Locations (1)
21201
University of Maryland Medical Center, Baltimore
All Listed Sponsors
lead
University of Maryland, Baltimore
OTHER
NCT01768442 - MRI for Eval Tumor & Node Response & Normal Tissue Function to Concurrent Chemo & Radiation Therapy in H&N Cancer (GCC1043) | Biotech Hunter | Biotech Hunter